16-67842563-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_020457.3(THAP11):āc.9C>Gā(p.Gly3Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,531,904 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0070 ( 14 hom., cov: 32)
Exomes š: 0.00067 ( 11 hom. )
Consequence
THAP11
NM_020457.3 synonymous
NM_020457.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.53
Genes affected
THAP11 (HGNC:23194): (THAP domain containing 11) The protein encoded by this gene contains a THAP domain, which is a conserved DNA-binding domain that has striking similarity to the site-specific DNA-binding domain (DBD) of Drosophila P element transposases. [provided by RefSeq, Jul 2008]
CENPT (HGNC:25787): (centromere protein T) The centromere is a specialized chromatin domain, present throughout the cell cycle, that acts as a platform on which the transient assembly of the kinetochore occurs during mitosis. All active centromeres are characterized by the presence of long arrays of nucleosomes in which CENPA (MIM 117139) replaces histone H3 (see MIM 601128). CENPT is an additional factor required for centromere assembly (Foltz et al., 2006 [PubMed 16622419]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 16-67842563-C-G is Benign according to our data. Variant chr16-67842563-C-G is described in ClinVar as [Benign]. Clinvar id is 1627825.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00699 (1064/152224) while in subpopulation AFR AF= 0.0242 (1004/41554). AF 95% confidence interval is 0.0229. There are 14 homozygotes in gnomad4. There are 521 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1064 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THAP11 | NM_020457.3 | c.9C>G | p.Gly3Gly | synonymous_variant | 1/1 | ENST00000303596.3 | NP_065190.2 | |
CENPT | NM_025082.4 | c.-492+4838G>C | intron_variant | ENST00000562787.6 | NP_079358.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THAP11 | ENST00000303596.3 | c.9C>G | p.Gly3Gly | synonymous_variant | 1/1 | 6 | NM_020457.3 | ENSP00000304689.1 | ||
CENPT | ENST00000562787.6 | c.-492+4838G>C | intron_variant | 2 | NM_025082.4 | ENSP00000457810.1 |
Frequencies
GnomAD3 genomes AF: 0.00700 AC: 1065AN: 152108Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
1065
AN:
152108
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00172 AC: 246AN: 143238Hom.: 3 AF XY: 0.00123 AC XY: 93AN XY: 75798
GnomAD3 exomes
AF:
AC:
246
AN:
143238
Hom.:
AF XY:
AC XY:
93
AN XY:
75798
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000666 AC: 919AN: 1379680Hom.: 11 Cov.: 30 AF XY: 0.000559 AC XY: 379AN XY: 677828
GnomAD4 exome
AF:
AC:
919
AN:
1379680
Hom.:
Cov.:
30
AF XY:
AC XY:
379
AN XY:
677828
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00699 AC: 1064AN: 152224Hom.: 14 Cov.: 32 AF XY: 0.00700 AC XY: 521AN XY: 74442
GnomAD4 genome
AF:
AC:
1064
AN:
152224
Hom.:
Cov.:
32
AF XY:
AC XY:
521
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
THAP11-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at